HALO
Halozyme Therapeutics, Inc.
$95.80−0.17 (−0.18%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Mar 16, 2004 – Nov 18, 2026, Dividends reinvested
- Final balance
- $225,412
- CAGR
- +14.73%
- Max drawdown
- −74.26%
Trailing returns (%)
HALO's average annual return was 22.27% over the last 10 years and 19.58% over the last 20 years, through Nov 18, 2026. $10,000 in HALO on Nov 18, 2016 grew to $74,669 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- −21.37%
- 3M
- −8.67%
- 6M
- +42.05%
- YTD
- +42.35%
- 1Y
- +36.66%
Per year
- 3Y
- +33.87%
- 5Y
- +22.03%
- 10Y
- +22.27%
- 15Y
- +17.74%
- 20Y
- +19.58%
- Since 2004
- +14.73%
Annual returns
2004 from Mar 16 · 2026 through Nov 18
HALO returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | +42.35% |
| 2025 | +40.77% |
| 2024 | +29.36% |
| 2023 | −35.04% |
| 2022 | +41.51% |
| 2021 | −5.85% |
| 2020 | +140.89% |
| 2019 | +21.19% |
| 2018 | −27.79% |
| 2017 | +105.06% |
| 2016 | −42.99% |
| 2015 | +79.59% |
Metrics
Since 2004| Volatility | 58.05% |
|---|---|
| Sharpe ratio | 0.53 |
| Sortino ratio | 0.80 |
| Calmar ratio | 0.20 |
| Longest drawdown | 4.8 years |
Worst drawdowns
Since 2004| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −74.3% | Jun 2007 | Dec 2008 | Feb 2012 | 4.7 years |
| −71.0% | Jul 2015 | Feb 2016 | May 2020 | 4.8 years |
| −69.1% | Apr 2004 | Aug 2004 | Dec 2006 | 2.6 years |
| −67.8% | Mar 2012 | Aug 2012 | Nov 2013 | 1.6 years |
| −59.6% | Jan 2014 | May 2014 | May 2015 | 1.3 years |